BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health an… Read more
BioHarvest Sciences Inc. Common Stock (BHST) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.270x
Based on the latest financial reports, BioHarvest Sciences Inc. Common Stock (BHST) has a cash flow conversion efficiency ratio of -0.270x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.09 Million) by net assets ($7.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioHarvest Sciences Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how BioHarvest Sciences Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BioHarvest Sciences Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioHarvest Sciences Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Financiere Moncey S.A.
PA:FMONC
|
0.004x |
|
Arsan Tekstil Ticaret ve Sanayi AS
IS:ARSAN
|
0.015x |
|
Xplora Technologies As
OL:XPLRA
|
0.295x |
|
Taylor Calvin B Bksh
OTCQX:TYCB
|
0.040x |
|
Happy Belly Food Group Inc.
OTCQB:HBFGF
|
0.225x |
|
Dohome Public Company Limited
BK:DOHOME
|
0.026x |
|
CBRAIN AS DK -25
F:C6F
|
N/A |
|
FABRYKA FARB I LAK. ZY 1
F:695
|
N/A |
Annual Cash Flow Conversion Efficiency for BioHarvest Sciences Inc. Common Stock (2020–2024)
The table below shows the annual cash flow conversion efficiency of BioHarvest Sciences Inc. Common Stock from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.33 Million | $-6.68 Million | -5.026x | -975.91% |
| 2023-12-31 | $-14.85 Million | $-8.52 Million | 0.574x | -63.19% |
| 2022-12-31 | $-5.93 Million | $-9.24 Million | 1.559x | +165.50% |
| 2021-12-31 | $2.85 Million | $-6.79 Million | -2.380x | -240.94% |
| 2020-12-31 | $-2.29 Million | $-3.88 Million | 1.688x | -- |